Pharming Group NV (PHAR) — Cash Flow-to-Debt Ratio
Pharming Group NV (PHAR) has a Cash Flow-to-Debt Ratio of 0.01x as of March 2026, meaning its operating cash flow of $1.63 Million could theoretically repay 0% of its total liabilities ($220.41 Million) in one year. See cash generation quality of Pharming Group NV to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Pharming Group NV Cash Flow-to-Debt Ratio (2005–2025)
Historical debt coverage capacity for Pharming Group NV across 21 annual periods. Also explore net asset growth rate of Pharming Group NV to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Pharming Group NV (2005–2025)
Year-by-year debt coverage analysis for Pharming Group NV. For market capitalisation and broader financial context, see market value of Pharming Group NV.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | $50.07 Million | $222.79 Million | ▲ +2340.0% |
| 2024 | -0.01x | $-1.79 Million | $178.92 Million | ▲ +85.8% |
| 2023 | -0.07x | $-17.30 Million | $244.07 Million | ▼ -169.8% |
| 2022 | 0.10x | $22.46 Million | $221.16 Million | ▼ -45.2% |
| 2021 | 0.19x | $37.84 Million | $204.40 Million | ▼ -57.4% |
| 2020 | 0.43x | $83.63 Million | $192.39 Million | ▼ -18.8% |
| 2019 | 0.54x | $74.15 Million | $138.53 Million | ▲ +102.6% |
| 2018 | 0.26x | $46.19 Million | $174.81 Million | ▲ +1.9% |
| 2017 | 0.26x | $45.84 Million | $176.82 Million | ▲ +357.4% |
| 2016 | -0.10x | $-10.52 Million | $104.45 Million | ▲ +79.2% |
| 2015 | -0.49x | $-17.95 Million | $37.00 Million | ▼ -137.9% |
| 2014 | -0.20x | $-6.42 Million | $31.46 Million | ▲ +35.1% |
| 2013 | -0.31x | $-11.45 Million | $36.45 Million | ▲ +25.1% |
| 2012 | -0.42x | $-13.58 Million | $32.40 Million | ▲ +30.9% |
| 2011 | -0.61x | $-20.34 Million | $33.55 Million | ▼ -218.4% |
| 2010 | -0.19x | $-6.89 Million | $36.16 Million | ▲ +57.4% |
| 2009 | -0.45x | $-27.24 Million | $60.99 Million | ▼ -138.7% |
| 2008 | -0.19x | $-14.21 Million | $75.96 Million | ▲ +31.4% |
| 2007 | -0.27x | $-31.69 Million | $116.14 Million | ▲ +59.3% |
| 2006 | -0.67x | $-25.89 Million | $38.59 Million | ▲ +69.5% |
| 2005 | -2.20x | $-15.26 Million | $6.93 Million | — |